Dr Vessely | Cosmetic Services | XEOMIN®

Dr. Vessely has been selected as one of the first physicians in the country to offer XEOMIN to her patients. XEOMIN is similar to BOTOX® Cosmetic, and is used to treat a variety of muscles to diminish lines of facial expression. It is FDA approved to temporarily improve the look of moderate to severe frown lines between the eyebrows (glabellar lines) in adults, but Dr. Vessely can use XEOMIN to treat any area that she feels it would be of benefit to her patients.

One of the reported benefits of XEOMIN is that is has less protein, potentially reducing the risk of sensitivies or antibodies developing from repeated treatments. In general, the onset of action and duration are thought to be similar to that of BOTOX® Cosmetic and Dysport. XEOMIN has been used for several years in Europe for cosmetic purposes and has been used in the US since 2010 to treat other medical conditions.
 
For more information, consider scheduling a consultation with Dr. Vessely to determine if XEOMIN is a good choice for your particular needs.
 

Call 503-692-1190 to schedule a complimentary consultation.
Discover where art and science meet to create a beautiful new you.

Stay informed of the latest news & specials.
Email:
Or join our mailing list by text message:
Stacks Image 961
DRVESSELY
to 22828 to get started
You will not find images reflecting society's definition of feminine perfection and beauty on this website. Instead, I've chosen to display images of nature's beauty. I believe that each of us is beautiful, with unique features, and the goal in my cosmetic practice is to help you protect, enhance and refine your natural beauty, preserving your unique and individual features.

View any of the links below to learn more about the cosmetic services Dr. Vessely offers:

The photos on this website, with the exception of the lavender header, are all taken by my daughter.
She has an eye for seeing the unique and beautiful in nature, just as I have an eye for seeing the unique and beautiful in my patients.